MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells.
Ichimura
Atsuhiko
A
Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho Sakyo-ku, Kyoto 606-8501, Japan.
Ruike
Yoshinao
Y
Terasawa
Kazuya
K
Shimizu
Kazuharu
K
Tsujimoto
Gozoh
G
D015152:Blotting, Northern; D002454:Cell Differentiation; D049109:Cell Proliferation; D047369:Chromatin Immunoprecipitation; D005434:Flow Cytometry; D020869:Gene Expression Profiling; D006801:Humans; D020014:K562 Cells; D048369:MAP Kinase Kinase 1 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008533:Megakaryocytes / Q000166:cytology*; D035683:MicroRNAs / Q000235:genetics / Q000502:physiology*; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D015398:Signal Transduction; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
C522425:MIRN34 microRNA, human; D035683:MicroRNAs; D016760:Proto-Oncogene Proteins c-fos; D048369:MAP Kinase Kinase 1; D013755:Tetradecanoylphorbol Acetate